Sarah M. McWhirter
Intarcia Therapeutics (United States)(US)
Publications by Year
Research Areas
interferon and immune responses, Cytokine Signaling Pathways and Interactions, Virus-based gene therapy research, Cancer Immunotherapy and Biomarkers, RNA modifications and cancer
Most-Cited Works
- → IKKε and TBK1 are essential components of the IRF3 signaling pathway(2003)2,672 cited
- → Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity(2015)1,453 cited
- → STING agonist formulated cancer vaccines can cure established tumors resistant to PD-1 blockade(2015)688 cited
- → IFN-regulatory factor 3-dependent gene expression is defective in Tbk1 -deficient mouse embryonic fibroblasts(2003)537 cited
- → The host STING pathway at the interface of cancer and immunity(2016)479 cited
- → Magnitude of Therapeutic STING Activation Determines CD8+ T Cell-Mediated Anti-tumor Immunity(2018)421 cited
- → SLC19A1 transports immunoreactive cyclic dinucleotides(2019)379 cited
- → Phase I Dose-Escalation Trial of MIW815 (ADU-S100), an Intratumoral STING Agonist, in Patients with Advanced/Metastatic Solid Tumors or Lymphomas(2021)338 cited
- → Multiple Functions of the IKK-Related Kinase IKKε in Interferon-Mediated Antiviral Immunity(2007)337 cited
- → A host type I interferon response is induced by cytosolic sensing of the bacterial second messenger cyclic-di-GMP(2009)296 cited